A major limitation in the therapy of cancer is the onset of drug resistance. In this regard, the cisplatin analogue 1R,2R-diaminocyclohexane(trans-diacetato)(dichloro)platinum IV (DAP) will undergo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback